In March 2024, following the results of the SELECT study, the U.S
Beyond-use dates explained Every compounded tirzepatide vial carries a beyond-use date (BUD) set by the compounding pharmacy
Shantelle is fantastic, she is very knowledgeable in every procedure she does, very clear and honest at front
However, compounded semaglutide lacks the rigorous FDA approval and oversight that Wegovy benefits from, leading to potential inconsistencies in formulation, dosage, and safety
The tirzepatide gallbladder connection is a more serious consideration that patients with gallbladder history should discuss with their physician before starting
However, insurance often limits GLP-1 coverage and may require prior authorization, BMI documentation, medical history, or step therapy